1. Home
  2. BZUN vs ENLV Comparison

BZUN vs ENLV Comparison

Compare BZUN & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Baozun Inc.

BZUN

Baozun Inc.

HOLD

Current Price

$2.52

Market Cap

159.3M

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$4.86

Market Cap

149.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BZUN
ENLV
Founded
2007
2005
Country
China
Israel
Employees
6762
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
159.3M
149.0M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
BZUN
ENLV
Price
$2.52
$4.86
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$20.00
AVG Volume (30 Days)
263.4K
377.1K
Earning Date
05-20-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.89
N/A
Revenue Next Year
$6.16
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.07
$0.43
52 Week High
$4.88
$7.64

Technical Indicators

Market Signals
Indicator
BZUN
ENLV
Relative Strength Index (RSI) 35.57 65.46
Support Level $2.44 $0.79
Resistance Level $2.58 $7.64
Average True Range (ATR) 0.12 0.45
MACD -0.04 0.36
Stochastic Oscillator 5.21 59.51

Price Performance

Historical Comparison
BZUN
ENLV

About BZUN Baozun Inc.

Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Share on Social Networks: